Germans Want to Save Animals by Suing Scientists

File PhotoA legal initiative is underway in Germany to give animal-rights organizations the standing to sue scientists and others who violate animal rights granted in a 2002 amendment to the German constitution. Animal-rights activists argue that the constitution offers no way of enforcing those rights. "Animal experiments have to be 'necessary' and 'ethically justified,' but those are vague legal terms," says Eisenhart von Loeper, an attorney and chairman of People for Animal Rights Germany. "T

Written byMartina Habeck
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

File Photo

A legal initiative is underway in Germany to give animal-rights organizations the standing to sue scientists and others who violate animal rights granted in a 2002 amendment to the German constitution. Animal-rights activists argue that the constitution offers no way of enforcing those rights. "Animal experiments have to be 'necessary' and 'ethically justified,' but those are vague legal terms," says Eisenhart von Loeper, an attorney and chairman of People for Animal Rights Germany. "There is almost no help from the courts to work out what this actually means."

To the scientific community in Germany, the initiative is a threat to basic research in their country. "Scientists wouldn't be able to plan ahead any longer," says Heinz Brandstetter at the Max Planck Institute of Biochemistry in Martinsried. He reckons the chances of animal-rights groups winning court cases are low, but any court action may considerably delay the experiments in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies